Restless Legs Syndrome as a Comorbidity in Rheumatoid Arthritis

Rheumatoid arthritis (RA) is a multisystem disease with a complex immunologic pathophysiology. Likewise, sleep disorders can involve a complicated interplay between the neurologic pathways, immune system, and respiratory system. Recent studies have shown an elevated prevalence of sleep abnormalities in connective tissue disorders compared to the general population. Restless legs syndrome (RLS) may be present in up to 30% of RA patients. These findings may be related to cytokine release and other immunomodulatory responses. TNF-α levels relate to sleep physiology and anti-TNF-α therapy may improve sleep patterns. Most of the patients with this disorder can distinguish their RLS sensations from their arthritic symptoms. RLS is a common comorbidity seen with RA, and prompt recognition and treatment can improve patient quality of life

A comparison in a Saskatchewan population between clinical diagnosis of asthma and American Thoracic Society Forced Expiratory Volume at one second (FEV1) post-bronchodilator improvement criteria

Background: The diagnosis of asthma can be challenging and is based on clinical symptoms, physical examination, and pulmonary function tests. Most patients with asthma will have a significant post-bronchodilator response on spirometry indicating airway hyper-responsiveness. However, having a significant bronchodilator response by itself is not diagnostic of asthma. Also, the definition of a "significant" response is controversial. Many respirologists use the American Thoracic Society (ATS) post-bronchodilator response criteria of 12% (provided it is ≥ 200 ml) improvement in FEV1 (or FCV) from the baseline spirometry. -- Methods: This study retrospectively reviewed 644 patients who met the ATS criteria for a significant post-bronchodilator spirometric response. The staff respirologist's diagnosis of asthma, based on all clinical and pulmonary function data, was used as the standard for the diagnosis of asthma. -- Results: It was found that relying on spirometric criteria alone was inadequate in asthma diagnosis as only 54.7% of 310 patients meeting ATS bronchodilator response criteria were felt to have asthma clinically. Increasing the post-bronchodilator percent improvement from the ATS criteria only marginally improved diagnostic specificity and resulted in a decline in sensitivity. -- Conclusions: This further emphasizes the need to use spirometric criteria as a guide but not as an unimpeachable gold standard by which to make a diagnosis of asthma. The diagnosis of asthma depends on a combination of expert physician correlation of history, physical examination, and pulmonary function test results

A questionnaire assessment of physical function in hyperlipidemic patients

Background: A spectrum of myopathic manifestations has been recognized as associated with lipid lowering drug therapy (LLT), but their effect on quality of life and physical functioning is uncertain. We conducted a prospective cohort study in which physical functioning was the dependent variable, in patients with and without exposure to LLT. Methods: Consecutive patients attending a risk reduction clinic were invited to participate in a questionnaire study which included demographic data, muscular symptoms, the SF-36 Physical Function Score (PF), and the modified Health Assessment Questionnaire (mHAQ). Laboratory and co-morbidity data was recorded. Results: Of 117 consecutive patients invited to participate, 112 consented. Of these, 81 were receiving statins and/or fibrates as LLT and 31 were participating in a non-pharmacologic therapeutic program (NPT) of diet and exercise therapy. The mean age for the total population was 56.7 years (20-78): the LLT group 58.6 and NPT group 51.9 years. Women comprised 53% of the LLT group and 58% of the NPT. No significant differences in baseline lipid profiles, CK level, BMI, waist measurement, gender, cigarette smoking, alcohol consumption, non-steroidal anti-inflammatory drugs or acetaminophen use, frequency of myalgias, SF-36 PF or mHAQ scores were observed between groups. On comparison of gender groups, we observed that men receiving LLT had significantly better SF- 36 PF (p = 0.037) than men on NPT. There were no differences in SF-36 PF or mHAQ scores between groups for females. Conclusion: We found no adverse effects of LLT on physical functioning or quality of life. Indeed, men treated with LLT had significantly better SF-36 PF scores than men treated non-pharmacologically

The American Thoracic Society’s spirometric criteria alone is inadequate in asthma diagnosis

BACKGROUND: The diagnosis of asthma is based on clinical symptoms, physical examination and pulmonary function tests, and can be very challenging. Most patients with asthma have a significant postbronchodilator response on spirometry indicating airway hyperresponsiveness. However, having a significant bronchodilator response by itself is not diagnostic of asthma. The definition of a ‘significant’ response has also been controversial. Many respirologists use the American Thoracic Society (ATS) postbronchodilator response criteria of 12% (provided it is 200 mL or greater) improvement in forced expiratory volume in 1 s (or forced vital capacity) from the baseline spirometry